Clinical Trials Browser

INDUSTRY × Pancreatic Neoplasms × ixabepilone × Clear all

NCT00383149 2016-03-10

A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

Phase 2 Completed

58 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms